Chelmsford, Mass.-based Zoll won a $29.8 million contract from the Defense Supply Center in Philadelphia to provide its CCT defibrillators to the U.S. Army, Navy, Air Force, Marine Corps and federal agencies.
In August, Zoll won FDA approval for its LifeVest external defibrillator. CEO Richard Packer told MassDevice he thinks sales of that device alone could grow as large as the company’s total sales are today, about $400 million annually.
Andover, Mass.-based Philips Healthcare won a $26.6 million deal from the Dept. of Defense’s Philadelphia supply center to provide its HeartStart MRx defibrillators to the same cast of military and federal agencies.
Earlier this week Philips issued a voluntary recall of about 5,400 units of a similar defibrillator model, the HeartStart FR2+, after discovering a microchip failure that “may render the device inoperable.” No adverse events have been reported in connection with the recall.